RhumbLine Advisers’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $642 | Hold |
|
|||||
|
2023
Q3 | $942 | Hold |
|
|||||
|
2023
Q2 | $1.33K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $51K | Sell |
|
|||||
|
2021
Q4 | $190K | Sell |
|
|||||
|
2021
Q3 | $214K | Buy |
|
|||||
|
2021
Q2 | $286K | Sell |
|
|||||
|
2021
Q1 | $309K | Sell |
|
|||||
|
2020
Q4 | $295K | Buy |
|
|||||
|
2020
Q3 | $391K | Sell |
|
|||||
|
2020
Q2 | $635K | Buy |
|
|||||
|
2020
Q1 | $309K | Buy |
|
|||||
|
2019
Q4 | $624K | Buy |
|
|||||
|
2019
Q3 | $680K | Buy |
|
|||||
|
2019
Q2 | $829K | Buy |
|
|||||
|
2019
Q1 | $731K | Sell |
|
|||||
|
2018
Q4 | $404K | Buy |
|
|||||
|
2018
Q3 | $555K | Sell |
|
|||||
|
2018
Q2 | $577K | Buy |
|
|||||
|
2018
Q1 | $579K | Sell |
|
|||||
|
2017
Q4 | $683K | Sell |
|
|||||
|
2017
Q3 | $699K | Buy |
|
|||||
|
2017
Q2 | $844K | Buy |
|
|||||
|
2017
Q1 | $679K | Buy |
|
|||||
|
2016
Q4 | $565K | Buy |
|
|||||
|
2016
Q3 | $664K | Buy |
|
|||||
|
2016
Q2 | $343K | Buy |
|
|||||
|
2016
Q1 | $333K | Buy |
|
|||||
|
2015
Q4 | $454K | Buy |
|
|||||
|
2015
Q3 | $315K | Buy |
|
|||||
|
2015
Q2 | $485K | Sell |
|
|||||
|
2015
Q1 | $476K | Buy |
|
|||||
|
2014
Q4 | $343K | Sell |
|
|||||
|
2014
Q3 | $385K | Sell |
|
|||||
|
2014
Q2 | $471K | Buy |
|